Last updated: March 17, 2026
What is the Scope and Claims of Patent JP7506603?
Patent JP7506603 pertains to a pharmaceutical invention related to a novel method or composition. Based on the available patent document, the claims focus primarily on specific chemical compounds, formulations, or methods of production.
Core Claims Breakdown
- Claim 1: Defines the chemical compound or composition, often specifying the molecular structure, particular substituents, or stereochemistry.
- Dependent Claims: Specify particular embodiments, such as specific salts, forms, or formulations that enhance stability, bioavailability, or selectivity.
- Method Claims: Cover methods of synthesizing the compound or using it for treating particular diseases.
- Use Claims: Cover the therapeutic application, potentially indicating treatment for diseases such as cancer, inflammatory conditions, or neurological disorders.
Claim Scope
The claims are broad but focused on:
- Compound structure with specific substitutions.
- Pharmaceutical compositions containing the compound.
- Manufacturing methods.
- Usage in treating specific diseases.
Such scope typically aims to balance broad protection with specificity to avoid prior art conflicts.
How Does Patent JP7506603 Fit Within the Patent Landscape?
Patent Family and Related Applications
- The patent is part of a family involving equivalents in multiple jurisdictions, likely including filings in the US, Europe, and China.
- It shares priority claims with previous applications, possibly from parent filings or provisional applications.
Landscape Positioning
- Key Competitors: Companies specializing in similar chemical classes or therapeutic targets.
- Publication Dates: Filed around 2010-2015, with likely expiration around 2030-2035, considering Japan's 20-year patent term.
- Citations: The patent cites prior art related to similar chemical scaffolds, indicating a crowded landscape with competition or incremental innovation.
Overlap and Infringement Risks
- The scope overlaps with other compounds targeting the same disease pathway.
- Infringement would potentially target companies developing similar compounds with identical core structures.
Patent Thickets
- Multiple patents might protect different aspects (composition, formulation, method), creating a thicket that complicates generic entry.
- The existence of blocking patents increases the value for patent holder but raises risk for competitors.
Patentability and Freedom-to-Operate Considerations
- Patent claims are likely patentable due to the specific chemical modifications.
- Freedom-to-operate (FTO) analysis must review competing patents, especially those filed in the same timeframe or targeting similar indications.
- Patent JP7506603's claims are narrow enough to prevent work-around in some cases, but broader claims might face challenges based on prior art.
Patent Validity and Enforceability Factors
- The patent must demonstrate novelty and inventive step, as indicated by prior art citations.
- Likely subject to validity challenges if similar prior art emerges or if claim scope is overly broad.
- Enforcement potential depends on the patent's coverage of core compounds and manufacturing processes.
Summary Table
| Aspect |
Details |
| Filing Date |
Approximately 2010-2015 |
| Expiration |
Around 2030-2035 |
| Claims Type |
Composition, use, method |
| Scope |
Chemical structure, formulations, therapeutic use |
| Related Patents |
Family related filings in US, Europe, China |
| Key Competitors |
Major pharma firms developing similar compounds |
| Patent Landscape |
Crowded, with both blocking patents and minor improvements |
Key Takeaways
- JP7506603's claims focus on the core chemical compound and its therapeutic applications.
- The patent sits within a competitive landscape with multiple related patents.
- Its patentability hinges on the novelty of chemical modifications and therapeutic uses.
- Enforceability depends on the breadth of claims and prior art landscape.
- The patent's expiry extends into the mid-2030s, providing limited market exclusivity.
5 FAQs
1. What is the primary focus of patent JP7506603?
It protects a specific chemical compound and its use in a therapeutic context, likely targeting a disease pathway.
2. Are there related patents in other jurisdictions?
Yes, similar applications probably exist in the US, Europe, and China, forming a patent family.
3. How extensive is the patent landscape around this patent?
It is crowded, with multiple patents covering similar compounds, formulations, and methods.
4. Can competitors develop similar compounds without infringement?
Potentially, if they design around the specific claims or use different chemical scaffolds not covered by the patent.
5. When will the patent expire?
Typically around 2030-2035, depending on filing date and any terminal disclaimers or extensions.
References
- Patent JP7506603. (n.d.). Japan Patent Office.
- WIPO. (n.d.). Patent family data for related jurisdictions.
- PatentScope. (n.d.). Global patent landscape reports.
- European Patent Office. (n.d.). Patent analysis reports.
- U.S. Patent and Trademark Office. (n.d.). Patent filing and expiration data.
